BioNTech initiates clinical trial of mRNA-based malaria vaccine candidate
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German ...
BioNTech has initiated a first-in-human Phase 1 clinical trial of its BNT165b1 malaria vaccine candidate using mRNA technology, the German ...
After decades of work, the World Health Organisation endorsed the first-ever malaria vaccine last year - a historic milestone that ...
Africa will start talks with the World Health Organisation about getting the first approved malaria vaccine to the continent as ...
A potential new malaria vaccine has proved highly effective in a trial in babies in Africa, pointing to it one ...
Researchers from the University of Pretoria are conducting a study in the country after recording a rise in the number ...
Malaria is a top killer of children under five in the East African nation, and the vaccine is critically important ...
Malawi aims to immunise 120,000 children aged two years and under to assess the effectiveness of the pilot vaccine and ...